Effect of rectal administration of rebamipide on dextran sulfate sodium-induced colitis: Role of hepatocyte growth factor

Inflammation Research

Volumn 56, Issue 6, 2007, Pages 240-245

  Murai, R ^a   Kanbe, T ^a,b   Mukoyama, T ^b   Shimomura, T ^a   Hashiguchi, K ^a   Yoshida, Y ^a   Tsuchiya, H ^a   Hoshikawa, Y ^a   Kurimasa, A ^a   Shiota, G ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b SAN IN ROSAI HOSPITAL   (Japan)

Author keywords

Experimental colitis; Hepatocyte growth factor; Rebamipide; Rectal administration

Indexed keywords

DEXTRAN SULFATE; REBAMIPIDE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EPITHELIUM CELL; FEMALE; GENETIC TRANSDUCTION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIVER CELL; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; ULCERATIVE COLITIS; WESTERN BLOTTING;

ADMINISTRATION, RECTAL; ALANINE; ANIMALS; ANTICOAGULANTS; APOPTOSIS; CELL PROLIFERATION; COLITIS; DEXTRAN SULFATE; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; QUINOLONES;

EID: 34347406999     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-6100-z     Document Type: Article

References (27)

1. Faubion WA Jr, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid thrapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255-60.
2. Yamasaki K, Kanbe T, Chijiwa T, Ishikawa H, Morita S. Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol 1987; 142: 23-29.
3. Kleinne A, Kluge S, Peskar BM. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 1993; 38: 1441-9.
4. Yoshikawa T, Naito Y, Nakamura S, Nishimura S, Kaneko T, Iimura S. Effect of rebamipide on lipid peroxidation and gastric mucosal injury by indomethacin in rats. Drug Res 1993; 43: 1327-30.
5. Okayama M, Tsubouchi R, Nishio H, Kato S, Takeuchi K. Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced colitis. Digestion 2004; 70: 240-9.
6. Miyata M, Kasugai K, Ishikawa T, Kakumu S, Onishi M, Mori T. Rebamipide enema-new effective treatment for patients with corticosteroid dependent or resistant ulcerative colitis. Dig Dis Sci 2005; 50: S119-S23.
7. Makiyama K, Takeshima F, Hamamoto T. Efficacy of rebamipide enemas in active distal ulcrative colitis and procitis: A prospective study report. Dig Dis Sci 2005; 50: 2323-9.
8. Kishimoto S, Haruma K, Tari A, Sakurai K, Nakano M, Nakagawa Y. Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.Dig Dis Sci 2000; 45: 1608-16.
9. Iwai A, Iwashita E. Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamioide. Dig Dis Sci 1998; 43: 143S-7S.
10. Nakashima T, Maeda T, Nagamoto H, Kumakura T, Takai M, Mori T. Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats. Dig Dis Sci 2005; 50: S124-31.
11. Goke M, Kanai M, Podolsky DK. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Phys 1998; 274: G809-18.
12. Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Okudaira T et al. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 1995; 95: 1994-2003.
13. Hori K, Shiota G, Kawasaki H. Expression of hepatocyte growth factor and c-met receptor in gastric mucosa during gastric ulcer healing. Scand J Gastroenterol 2000; 35: 24-31.
14. Matsuno M, Shiota G, Umeki K, Kojyo H, Miura K, Kawasaki H. Induction of plasma hepatocyte growth factor in acute colitis of mice. Inflamm Res 1997; 46: 166-7.
15. Kitamura S, Kondo S, Shinomura Y, Isozaki K, Kanayama S, Higashimoto Y et al. Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm Res 2000; 49: 320-4.
16. Tahara Y, Ido A, Yamamoto S, Miyata Y, Uto H, Hori T et al. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 2004; 307: 146-51.
17. Mukoyama T, Kanbe T, Murai R, Murawaki Y, Shimomura T, Hashiguchi K et al. Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice. Biochem Biophys Rs Commun 2005; 329: 1217-24.
18. Kanbe T, Murai R, Mukoyama T, Murawaki Y, Hashiguchi K, Yoshida Y et al. Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice. Biochem Biophys Res Commun 2006; 345: 1517-25.
19. Adachi T, Nakashima S, Saji S, Nakamura T, Nozawa Y. Roles of prostaglandin production and mitogen-activated protein kinase activation in hepatocyte growth factor-mediated rat hepatocyte proliferation. Hepatology 1995; 21: 1668-74.
20. Matsumoto K, Okazaki H, Nakamura T. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J Biochem 1995; 117: 458-64.
21. Udagawa A, Shiota G, Ichiba M, Murawaki Y. Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of heptaocyte growth factor. Scand J Gastroenterol 2003; 38: 141-6.
22. Shiota G, Kunisada T, Oyama K, Udagawa K, Nomi T, Tanaka K et al. In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats. FEBS Lett 2000; 314: 325-30.
23. Kimvall ES, Palmer JM, D'Andrea MR, Hornby PJ, Wade PR. Acute colitis induction by oil of mustard results in later development of an IBS-like accelerated upper GI transit in mice. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1266-G73.
24. Takahashi M, Ota S, Hata Y, Mikami Y, Azuma N, Nakamura T et al. Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest 1996; 98: 2604-11.
25. Bamba H, Ota S, Kato A, Matsuzaki F. Nonsteroidal anti-inflammatory drugs delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 1998; 245: 567-71.
26. Murphy MJ, Wilson A and Trumpp A. More than just proliferation: Myc function in stem cells. Trends in Cell Biol 2005; 15: 128-37.
27. Collins RHJR, Feldman M, Fordtran JS.Colon cancer, dysplasia and surveillance in patients with ulcerative colitis, a critical review. N Engl J Med 1987; 316: 1654-8.